Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

Robert J Bitterman

CEO, Chair at Phio Pharmaceuticals Corp. (PHIO)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys−$4K
Total bought / sold$45K / $0

Reported trades

Filed Stock Type Shares Price Value Since
Sep 23SEC PHIOPhio Pharmaceuticals Corp. Buy 2,000364,871 held (+1%) $1.03 $2K -5.0%
Aug 19SEC PHIOPhio Pharmaceuticals Corp. Buy 10,000431,421 held (+2%) $1.06 $11K -7.6%
Jun 29SEC PHIOPhio Pharmaceuticals Corp. Buy 10,000421,421 held (+2%) $0.99 $10K -1.1%
Jan 2SEC PHIOPhio Pharmaceuticals Corp. Buy 5,000291,421 held (+2%) $1.03 $5K -5.0%
Dec 29SEC PHIOPhio Pharmaceuticals Corp. Buy 5,000286,421 held (+2%) $1.02 $5K -4.0%
Nov 24SEC PHIOPhio Pharmaceuticals Corp. Buy 5,000281,421 held (+2%) $1.14 $6K -14.1%
Nov 19SEC PHIOPhio Pharmaceuticals Corp. Buy 5,000276,421 held (+2%) $1.27 $6K -22.9%
  • Buy

    CEO, Chair Robert J Bitterman bought $11K of PHIO at $1.06 — largest purchase by this insider in our records.

  • Buy

    CEO, Chair Robert J Bitterman bought $10K of PHIO at $0.99 — largest purchase by this insider in our records.

  • Buy

    CEO, Chair Robert J Bitterman bought $6K of PHIO at $1.27 — first open-market purchase in our records.